AnBogen Therapeutics


Therapeutics (ABT) is a clinical stage biopharmaceutical company, registered in Taipei, Taiwan and focused on first/best-in-class precision medicine in oncology. Our therapeutic pipeline, ABT-101, addresses multiple unmet medical needs that represent large market opportunities
Rankings by

National Ranking87th
in Taiwan Regional Ranking757th
in East Asia Global Ranking13057th
worldwide